NanOlogy LLC, a clinical-stage oncology company, announces a presentation of clinical research involving its large surface area microparticle investigational drugs at DDW 2023 in May and publication at ASCO Annual Meeting in June.
NanOlogy LLC, a clinical-stage oncology company, announces a presentation of clinical research involving its large surface area microparticle investigational drugs at DDW 2023 in May and publication at ASCO Annual Meeting in June.